NCT01377831View on ClinicalTrials.gov

Study of Ketamine Administered Intravenously and by Sublingual Wafer

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Pain
Trial Locations (1)

5000

Pain and Anaesthesia Research Clinic (PARC), Royal Adelaide Hospital, Adelaide

All Listed Sponsors
lead

iX Biopharma Ltd.

OTHER

NCT01377831 - Study of Ketamine Administered Intravenously and by Sublingual Wafer | Biotech Hunter | Biotech Hunter